Notices. Notice
433 words·~2 min read·
/register/2023/10/11/2023-22465·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-N-0804; FDA-2010-N-0598; FDA-2022-N-0081; FDA-2022-N-1886; FDA-2022-N-2657; FDA-2023-N-0895; FDA-2023-N-0343; FDA-2023-N-0134; FDA-2022-N-3208; FDA-2017-N-0084; FDA-2023-N-1168; FDA-2016-N-2474; FDA-2014-N-0086; FDA-2017-N-0366; FDA-2019-N-3657; FDA-2023-N-0155; FDA-2010-N-0601; FDA-2023-N-2757] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794, *PRAStaff@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved by OMB Title of collection OMB control No. Date approval expires Premarket Notification Submission 510(k), Subpart E 0910-0120 7/31/2026 Good Manufacturing Practice Regulations for Type A Medicated Articles 0910-0154 7/31/2026 Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion 0910-0917 7/31/2026 Endorser Status and Actual Use in Direct-to-Consumer Television Ads 0910-0918 7/31/2026 Assessing Physiological, Neural and Self-Reported Response to Tobacco Education Messages 0910-0919 7/31/2026 Imports and Electronic Import Entries 0910-0046 8/31/2026 Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and “Lookback” 0910-0116 8/31/2026 Administrative Practices and Procedures; Formal Hearings 0910-0191 8/31/2026 Adverse Experience/Events with Approved New Animal Drugs 0910-0284 8/31/2026 Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) 0910-0471 8/31/2026 Human Cells, Tissues, and Cellular and Tissue-Based Products 0910-0543 8/31/2026 New Animal Drugs for Minor Use and Minor Species 0910-0605 8/31/2026 Potential Tobacco Product Violations Reporting Form 0910-0716 8/31/2026 Food and Drug Administration Advisory Committee Regulations 0910-0833 8/31/2026 Accreditation Scheme for Conformity Assessment Program 0910-0889 8/31/2026 Quantitative Research on Front of Package Labeling on Packaged Foods 0910-0920 8/31/2026 Current Good Manufacturing Practice Regulations for Medicated Feed 0910-0152 9/30/2026 Medical Devices—Voluntary Improvement Program 0910-0922 9/30/2026 Dated: October 5, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023-22465 Filed 10-10-23; 8:45 am]
Connectionstraces to 1
Traces to 1 document